R.G. Niederhoffer Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-5,200
Closed -$1.63M – 5
2016
Q3
$1.63M Buy
+5,200
New +$1.54M 7.88% 4
2015
Q4
– Sell
-2,700
Closed -$788K – 6
2015
Q3
$788K Buy
+2,700
New +$892K 3.89% 10
2015
Q2
– Sell
-4,500
Closed -$1.9M – 22
2015
Q1
$1.9M Buy
+4,500
New +$1.77M 15.63% 2
2014
Q2
– Sell
-6,100
Closed -$1.87M – 30
2014
Q1
$1.87M Buy
+6,100
New +$1.94M 7.61% 2

Other funds holding BIIB

R.G. Niederhoffer Capital Management's BIIB Position: Q4 2016 in Review

R.G. Niederhoffer Capital Management sold out of Biogen (BIIB) in Q4 2016, closing a stake of 5,200 shares — an estimated $1.63M sold.

R.G. Niederhoffer Capital Management first reported a position in BIIB in Q1 2014 and held it in 4 quarters. The position peaked at $1.9M in Q1 2015. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • R.G. Niederhoffer Capital Management reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • R.G. Niederhoffer Capital Management sold 5,200 Biogen shares in Q4 2016, an estimated $1.63M.
  • R.G. Niederhoffer Capital Management first reported a position in Biogen in Q1 2014 and held it in 4 quarters.
  • R.G. Niederhoffer Capital Management's Biogen position peaked at $1.9M in Q1 2015.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on R.G. Niederhoffer Capital Management's 13F filing for Q4 2016.